Deutsche Bank’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-12,203
Closed -$91.5K 3692
2025
Q2
$91.5K Sell
12,203
-21,386
-64% -$188K ﹤0.01% 3294
2025
Q1
$286K Hold
33,589
﹤0.01% 2783
2024
Q4
$1.2M Sell
33,589
-30,258
-47% -$1.57M ﹤0.01% 2139
2024
Q3
$3.02M Buy
63,847
+807
+1% +$35.6K ﹤0.01% 1518
2024
Q2
$3.17M Sell
63,040
-371
-0.6% -$26.8K ﹤0.01% 1416
2024
Q1
$7.1M Buy
63,411
+17,842
+39% +$1.77M ﹤0.01% 1140
2023
Q4
$2.64M Buy
45,569
+43,056
+1,713% +$1.73M ﹤0.01% 1529
2023
Q3
$79.8K Sell
2,513
-42,997
-94% -$2.04M ﹤0.01% 3258
2023
Q2
$3.74M Sell
45,510
-392
-0.9% -$57.3K ﹤0.01% 1340
2023
Q1
$4.72M Buy
45,902
+674
+1% +$94.6K ﹤0.01% 1265
2022
Q4
$6.63M Buy
45,228
+474
+1% +$80.1K ﹤0.01% 1115
2022
Q3
$7.56M Sell
44,754
-235
-0.5% -$38.2K ﹤0.01% 1056
2022
Q2
$5.2M Sell
44,989
-1,238
-3% -$116K ﹤0.01% 1263
2022
Q1
$4.61M Buy
46,227
+43,147
+1,401% +$5.04M ﹤0.01% 1460
2021
Q4
$479K Sell
3,080
-1,088
-26% -$212K ﹤0.01% 2882
2021
Q3
$982K Sell
4,168
-3,685
-47% -$1.08M ﹤0.01% 2625
2021
Q2
$2.67M Sell
7,853
-923
-11% -$349K ﹤0.01% 1967
2021
Q1
$3.55M Sell
8,776
-291
-3% -$141K ﹤0.01% 1774
2020
Q4
$6.03M Sell
9,067
-25,538
-74% -$14.2M ﹤0.01% 1269
2020
Q3
$16.1M Buy
34,605
+32,272
+1,383% +$16.3M 0.01% 780
2020
Q2
$1.36M Buy
2,333
+1,886
+422% +$644K ﹤0.01% 2028
2020
Q1
$65K Sell
447
-29
-6% -$5.07K ﹤0.01% 3424
2019
Q4
$68K Sell
476
-1,726
-78% -$126K ﹤0.01% 3787
2019
Q3
$86K Sell
2,202
-618
-22% -$44.9K ﹤0.01% 3632
2019
Q2
$285K Sell
2,820
-4,323
-61% -$509K ﹤0.01% 3629
2019
Q1
$938K Buy
7,143
+6,477
+973% +$815K ﹤0.01% 3034
2018
Q4
$67K Sell
666
-606
-48% -$95.9K ﹤0.01% 4368
2018
Q3
$318K Buy
1,272
+35
+3% +$11.7K ﹤0.01% 4014
2018
Q2
$552K Buy
1,237
+552
+81% +$242K ﹤0.01% 3794
2018
Q1
$269K Buy
685
+229
+50% +$90.4K ﹤0.01% 4042
2017
Q4
$187K Buy
456
+118
+35% +$51.5K ﹤0.01% 4057
2017
Q3
$144K Buy
338
+186
+122% +$73.3K ﹤0.01% 4032
2017
Q2
$53K Buy
+152
New +$52.6K ﹤0.01% 4363

Other funds holding MRSN